AstraZeneca PLC (LON:AZN)
London · Delayed Price · Currency is GBP · Price in GBX 12,032
-248 (-2.02%)
Oct 1, 2026, 5:15 PM GMT
AstraZeneca Market Cap
AstraZeneca has a market cap or net worth of 190.47 billion as of October 1, 2026. Its market cap has increased by 10.77% in one year.
Market Cap
190.47B
Enterprise Value
211.16B
Revenue
46.25B
Ranking
n/a
PE Ratio
24.39
Stock Price
12,032.00
ChartMarket Cap Chart
Since May 28, 1993, AstraZeneca's market cap has increased from 4.55B to 190.47B, an increase of 4,085.69%. That is a compound annual growth rate of 11.84%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 30, 2026 | 190.47B | -10.93% |
| Dec 31, 2025 | 213.85B | 31.77% |
| Dec 31, 2024 | 162.29B | -1.22% |
| Dec 29, 2023 | 164.29B | -5.48% |
| Dec 30, 2022 | 173.83B | 29.30% |
| Dec 31, 2021 | 134.44B | 39.83% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| GSK plc | 73.41B |
| Haleon | 29.74B |
| Smith & Nephew | 8.49B |
| Convatec Group | 4.24B |
| Hikma Pharmaceuticals | 3.40B |
| Oxford Nanopore Technologies | 2.12B |
| HUTCHMED (China) | 1.95B |
| Genus | 1.43B |